2 Cooley-Led Biotechs Price $920M In Follow-On Stock Sales
Two life science companies advised by Cooley LLP on Tuesday priced follow-on stock offerings totaling $920 million to expand their businesses, boosting a public offerings market that has been notably less receptive...To view the full article, register now.
Already a subscriber? Click here to view full article